Literature DB >> 28600929

Detrimental effects of self-administered methamphetamine during pregnancy on offspring development in the rat.

Daniela Rüedi-Bettschen1, Donna M Platt2.   

Abstract

BACKGROUND: Methamphetamine (METH) abuse by pregnant women is a commonly observed phenomenon. While the harmful effects of METH are well described for adults, there is only limited knowledge of the effects of METH use during pregnancy on the developing child. In the present study, we investigated how intraveneous (iv) METH self-administration throughout pregnancy affected rat dams and their offspring through weaning, compared to controls.
METHODS: Female rats (n=16) were trained to self-administer METH iv; every drug infusion by a dam also resulted in a saline injection to a yoked control (n=16). When stable levels of self-administration were reached, all females were mated. Daily, 2-h self-administration sessions continued until litters were born. General health and weight was assessed daily in dams and pups. In addition, pups were evaluated for achievement of age-appropriate developmental milestones (i.e., righting reflex, negative geotaxis, pinna detachment, fur appearance, incisor eruption and eye opening).
RESULTS: Dams self-administered 2-3mg/kg/day METH throughout gestation without consequence to dam health or weight gain during pregnancy. All females produced viable litters, and litter size and composition did not differ between saline and METH dams. Similarly, maternal pup-directed behavior was not affected by prior METH self-administration. However, despite a lack of weight difference in pups, METH-exposed pups were significantly delayed in reaching all assessed developmental milestones compared to controls.
CONCLUSION: These results indicate that in utero exposure to moderate METH doses can profoundly and adversely affect offspring development, suggesting that even recreational METH use during pregnancy has potential for harm.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Animal model; Methamphetamine; Neurodevelopment; Pregnancy; Self-administration

Mesh:

Substances:

Year:  2017        PMID: 28600929      PMCID: PMC5701573          DOI: 10.1016/j.drugalcdep.2017.03.042

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  44 in total

Review 1.  Importance of studying the contributions of early adverse experience to neurobiological findings in depression.

Authors:  Christine Heim; Paul M Plotsky; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

2.  Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats.

Authors:  R Galici; R N Pechnick; R E Poland; C P France
Journal:  Eur J Pharmacol       Date:  2000-01-03       Impact factor: 4.432

3.  Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine.

Authors:  Anne Bartu; Leon J Dusci; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

Review 4.  Drugs in pregnancy: the effects on mother and her progeny.

Authors:  R Šlamberová
Journal:  Physiol Res       Date:  2012       Impact factor: 1.881

5.  Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Authors:  Rizwan Shah; Sabrina D Diaz; Amelia Arria; Linda L LaGasse; Chris Derauf; Elana Newman; Lynne M Smith; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Mary B Roberts; Charles Neal; Barry M Lester
Journal:  Am J Perinatol       Date:  2012-03-07       Impact factor: 1.862

6.  Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug.

Authors:  S I Dworkin; S Mirkis; J E Smith
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

7.  Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.

Authors:  Lynne M Smith; Monica S Paz; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Depress Anxiety       Date:  2012-05-03       Impact factor: 6.505

8.  Behavioral teratogenicity of methamphetamine.

Authors:  D H Cho; H M Lyu; H B Lee; P Y Kim; K Chin
Journal:  J Toxicol Sci       Date:  1991-02       Impact factor: 2.196

Review 9.  An evolving problem: methamphetamine production and trafficking in the United States.

Authors:  Rashi K Shukla; Jordan L Crump; Emelia S Chrisco
Journal:  Int J Drug Policy       Date:  2012-09-01

10.  Methamphetamine use among pregnant women.

Authors:  Mishka Terplan; Erica J Smith; Michael J Kozloski; Harold A Pollack
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

View more
  2 in total

1.  Early-life stress induces EAAC1 expression reduction and attention-deficit and depressive behaviors in adolescent rats.

Authors:  Han-Byeol Kim; Ji-Young Yoo; Seung-Yeon Yoo; Sang Won Suh; Seoul Lee; Ji Hye Park; Jun-Ho Lee; Tai-Kyoung Baik; Hye-Sun Kim; Ran-Sook Woo
Journal:  Cell Death Discov       Date:  2020-08-08

2.  Alteration in the time and/or mode of delivery differentially modulates early development in mice.

Authors:  Morgane Chiesa; Diana C Ferrari; Yehezkel Ben-Ari
Journal:  Mol Brain       Date:  2020-03-09       Impact factor: 4.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.